Found: 5000
Select item for more details and to access through your institution.
FDA OKs Lazertinib With Amivantamab-vmjw for Non-Small Cell Lung Cancer.
- Published in:
- Oncology Practice Management, 2024, v. 14, n. 9, p. 17
- Publication type:
- Article
Correlation of Immunomodulatory Cytokines with Tumor Volume and Cerebrospinal Fluid in Vestibular Schwannoma Patients.
- Published in:
- Cancers, 2024, v. 16, n. 17, p. 3002, doi. 10.3390/cancers16173002
- By:
- Publication type:
- Article
Assessment of the effect of the SLC5A2 gene on eGFR: a Mendelian randomization study of drug targets for the nephroprotective effect of sodium-glucose cotransporter protein 2 inhibition.
- Published in:
- Frontiers in Endocrinology, 2024, p. 1, doi. 10.3389/fendo.2024.1418575
- By:
- Publication type:
- Article
PARP1 promotes EGFR-TKI drug-resistance via PI3K/AKT pathway in non-small-cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2024, v. 94, n. 2, p. 209, doi. 10.1007/s00280-024-04668-2
- By:
- Publication type:
- Article
Immunohistochemical Expression of ER, PR, and HER2/Neu in Breast Carcinoma -A Cross Sectional Study.
- Published in:
- Journal of Cardiovascular Disease Research (Journal of Cardiovascular Disease Research), 2024, v. 15, n. 8, p. 1184
- By:
- Publication type:
- Article
A study of thyroid function abnormalities in patients with chronic kidney disease.
- Published in:
- Journal of Cardiovascular Disease Research (Journal of Cardiovascular Disease Research), 2024, v. 15, n. 8, p. 639
- By:
- Publication type:
- Article
Role of Acoustic Radiation Force Impulse (ARFI) elastography and renal doppler in the evaluation of chronic kidney disease.
- Published in:
- Journal of Cardiovascular Disease Research (Journal of Cardiovascular Disease Research), 2024, v. 15, n. 7, p. 1122
- By:
- Publication type:
- Article
Effects of MAFLD defined by fatty liver index or ultrasonography on kidney function decline in the general population.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-72482-0
- By:
- Publication type:
- Article
Estimation of renal function immediately after cessation of continuous renal replacement therapy at the ICU.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-72069-9
- By:
- Publication type:
- Article
Phase II clinical trial of docetaxel and trastuzumab for HER2-positive advanced extramammary Paget's disease (EMPD-HER2DOC).
- Published in:
- Oncologist, 2024, v. 29, n. 9, p. e1201, doi. 10.1093/oncolo/oyae097
- By:
- Publication type:
- Article
Adjuvant treatment strategy evolution and risk stratification for hormone receptor-positive, human epidermal growth factor receptor-2 negative early breast cancer in China.
- Published in:
- Oncologist, 2024, v. 29, n. 9, p. e1104, doi. 10.1093/oncolo/oyae095
- By:
- Publication type:
- Article
Health-related quality of life with sacituzumab govitecan in HR+/HER2− metastatic breast cancer in the phase III TROPiCS-02 trial.
- Published in:
- Oncologist, 2024, v. 29, n. 9, p. 768, doi. 10.1093/oncolo/oyae088
- By:
- Publication type:
- Article
Liquid silicone gel injection leading to primary squamous cell carcinoma of the breast.
- Published in:
- Kaohsiung Journal of Medical Sciences, 2024, v. 40, n. 9, p. 862, doi. 10.1002/kjm2.12874
- By:
- Publication type:
- Article
A histomorphological and immunohistochemical analysis of invasive lobular carcinoma of breast: A case series.
- Published in:
- Asian Journal of Medical Sciences, 2024, v. 15, n. 9, p. 206, doi. 10.3126/ajms.v15i9.66833
- By:
- Publication type:
- Article
Effect of neoadjuvant chemotherapy on the expression of hormone receptors and Ki-67 in patients with locally advanced breast cancer.
- Published in:
- Asian Journal of Medical Sciences, 2024, v. 15, n. 9, p. 149, doi. 10.3126/ajms.v15i9.66256
- By:
- Publication type:
- Article
Longitudinal Trajectories of Estimated Glomerular Filtration Rate in a European Population of Living Kidney Donors.
- Published in:
- Transplant International, 2024, p. 1, doi. 10.3389/ti.2024.13356
- By:
- Publication type:
- Article
Combining antivascular endothelial growth factor and anti-epidermal growth factor receptor antibodies: randomized phase II study of irinotecan and cetuximab with/without ramucirumab in second-line colorectal cancer (ECOG-ACRIN E7208).
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1487, doi. 10.1093/jnci/djae114
- By:
- Publication type:
- Article
Managed Care Considerations in the Treatment of HER2-Positive Advanced Breast Cancer: A Closer Look at Recent Advances for Improved Patient Outcomes.
- Published in:
- Journal of Managed Care Medicine, 2024, v. 27, n. 2, p. 40
- By:
- Publication type:
- Article
A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer.
- Published in:
- NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00684-w
- By:
- Publication type:
- Article
Clinical utility of repeated rebiopsy for EGFR T790M mutation detection in non-small cell lung cancer.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1452947
- By:
- Publication type:
- Article
Reference intervals of circulating secretoneurin concentrations determined in a large cohort of community dwellers: the HUNT study.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2024, v. 62, n. 10, p. 2030, doi. 10.1515/cclm-2024-0154
- By:
- Publication type:
- Article
Correction to: DNA variants detected in primary and metastatic lung adenocarcinoma: a case report and review of the literature.
- Published in:
- 2024
- Publication type:
- Correction Notice
DNA variants detected in primary and metastatic lung adenocarcinoma: a case report and review of the literature.
- Published in:
- Laboratory Medicine, 2024, v. 5, n. 5, p. 658, doi. 10.1093/labmed/lmae019
- By:
- Publication type:
- Article
Deoxybouvardin targets EGFR, MET, and AKT signaling to suppress non-small cell lung cancer cells.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-70823-7
- By:
- Publication type:
- Article
Clinical efficacy of Apatinib combined with Epidermal growth factor receptor - tyrosine kinase inhibitor (EGFR-TKI) in nonsmall cell lung cancer after EGFR-TKI resistance.
- Published in:
- Pakistan Journal of Medical Sciences, 2024, v. 40, n. 8, p. 1714, doi. 10.12669/pjms.40.8.9682
- By:
- Publication type:
- Article
Prospective study of the effect of rituximab on kidney function in membranous nephropathy.
- Published in:
- Clinical Kidney Journal, 2024, v. 17, n. 8, p. 1, doi. 10.1093/ckj/sfae179
- By:
- Publication type:
- Article
Protein Kinase Inhibitors Indicated for Lung Cancer: Pharmacodynamics, Pharmacokinetics, Adverse Drug Reactions, and Evaluation in Clinical Trials.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2024, v. 2024, p. 1, doi. 10.1155/2024/5437090
- By:
- Publication type:
- Article
Targeted radionuclide therapy for head and neck squamous cell carcinoma: a review.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1445191
- By:
- Publication type:
- Article
Non-small Cell Lung Cancer with Metachronous Mutations of EGFR and ALK Genes: A Case Report and Literature Review.
- Published in:
- Chinese Journal of Lung Cancer, 2024, v. 27, n. 7, p. 559, doi. 10.3779/j.issn.1009-3419.2024.106.15
- By:
- Publication type:
- Article
Chinese Expert Consensus on the Standardized Diagnosis and Treatment of Non-small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations (2024 Edition).
- Published in:
- Chinese Journal of Lung Cancer, 2024, v. 27, n. 7, p. 485, doi. 10.3779/j.issn.1009-3419.2024.102.27
- By:
- Publication type:
- Article
Neoadjuvant Chemotherapy and Pathologic Complete Response in HR+/HER2− Breast Cancer: Impact of Tumor Ki67 and ER Status.
- Published in:
- Chemotherapy (0009-3157), 2024, v. 69, n. 3, p. 141, doi. 10.1159/000537874
- By:
- Publication type:
- Article
Characteristics of sphingomyelin metabolism in the MCF7 and BT474 radiotherapy‑resistant HER2‑positive breast cancer cell lines.
- Published in:
- Oncology Letters, 2024, v. 28, n. 4, p. N.PAG, doi. 10.3892/ol.2024.14604
- By:
- Publication type:
- Article
Atractyloside inhibits gefitinib‑resistant non‑small‑cell lung cancer cell proliferation.
- Published in:
- Oncology Letters, 2024, v. 28, n. 4, p. N.PAG, doi. 10.3892/ol.2024.14599
- By:
- Publication type:
- Article
Targeting the epidermal growth factor receptor (EGFR/ErbB) for the potential treatment of renal pathologies.
- Published in:
- Frontiers in Pharmacology, 2024, p. 01, doi. 10.3389/fphar.2024.1394997
- By:
- Publication type:
- Article
Prevalence and clinical factors associated with survival in patients with EGFR-mutated lung cancer in Argentina.
- Published in:
- Ecancermedicalscience, 2024, v. 18, n. 1676-1753, p. 1, doi. 10.3332/ecancer.2024.1737
- By:
- Publication type:
- Article
Prevalence and treatment of human epidermal growth factor receptor 2-altered non-small cell lung cancer: a retrospective analysis and systematic literature review.
- Published in:
- Ecancermedicalscience, 2024, v. 18, n. 1676-1753, p. 1, doi. 10.3332/ecancer.2024.1734
- By:
- Publication type:
- Article
Reduced frequency dosing of osimertinib in EGFR-mutant non-small cell lung carcinoma: real world data.
- Published in:
- Ecancermedicalscience, 2024, v. 18, n. 1676-1753, p. 1, doi. 10.3332/ecancer.2024.1721
- By:
- Publication type:
- Article
Subcutaneous versus intravenous administration of Trastuzumab: a minimization cost analysis with real world data from a reference cancer centre in Peru.
- Published in:
- Ecancermedicalscience, 2024, v. 18, n. 1676-1753, p. 1, doi. 10.3332/ecancer.2024.1708
- By:
- Publication type:
- Article
Breast cancer burden in eastern Sudan: seven-year retrospective study.
- Published in:
- Ecancermedicalscience, 2024, v. 18, n. 1676-1753, p. 1, doi. 10.3332/ecancer.2024.1704
- By:
- Publication type:
- Article
Natural killer cells: a future star for immunotherapy of head and neck squamous cell carcinoma.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1442673
- By:
- Publication type:
- Article
Osimertinib prolongs progression‐free lung cancer survival after chemotherapy.
- Published in:
- CA: A Cancer Journal for Clinicians, 2024, v. 74, n. 5, p. 402, doi. 10.3322/caac.21862
- By:
- Publication type:
- Article
Nerve growth factor inducible (VGF) is a secreted mediator for metastatic breast cancer tropism to the brain.
- Published in:
- Journal of Pathology, 2024, v. 264, n. 2, p. 132, doi. 10.1002/path.6319
- By:
- Publication type:
- Article
EPIDERMAL GROWTH FACTOR RECEPTOR OVEREXPRESSION IN TRIPLE NEGATIVE BREAST CANCER.
- Published in:
- JPMI: Journal of Postgraduate Medical Institute, 2024, v. 38, n. 2, p. 140, doi. 10.54079/jpmi.38.2.3329
- By:
- Publication type:
- Article
The use of nanomaterials as drug delivery systems and anticancer agents in the treatment of triple-negative breast cancer: an updated review (year 2005 to date).
- Published in:
- Discover Nano, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s11671-024-04089-3
- By:
- Publication type:
- Article
Racial/ethnic differences in the clinical presentation and survival of breast cancer by subtype.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1443399
- By:
- Publication type:
- Article
Expanding treatment options for patients with HER2+ metastatic breast cancer with margetuximab plus chemotherapy: a case report series.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1419246
- By:
- Publication type:
- Article
Visualizing Singularity Phenomenon.
- Published in:
- Biophysics & Physicobiology, 2024, v. 21, p. 1, doi. 10.2142/biophysico.bppb-v21.s011
- By:
- Publication type:
- Article
Molecular analysis of genetic mutations in non-small cell lung cancer in Morocco.
- Published in:
- Pan African Medical Journal, 2024, v. 47, p. 1, doi. 10.11604/pamj.2024.47.116.42973
- By:
- Publication type:
- Article
Genomic profiling of colorectal cancer in large-scale Chinese patients: amplification and somatic mutations in ERBB2.
- Published in:
- Oncology Research, 2024, v. 32, n. 9, p. 1429, doi. 10.32604/or.2024.047309
- By:
- Publication type:
- Article
Case report: outcome of anlotinib treatment in breast cancer patient with brain metastases.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1381478
- By:
- Publication type:
- Article